ConductScience.org, home

Trial · NCT04055909

Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock

NCT04055909, Phase 2, Active not recruiting, Inotrem

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock. Trials, record NCT04055909. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04055909

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock
NCT number
NCT04055909
Status
Active not recruiting
Phases
Phase 2
Enrollment
355 participants, actual
Lead sponsor
Inotrem
Conditions
Shock, Septic
Interventions
nangibotide low dose, nangibotide high dose, placebo
First posted
2019-08-14
Last updated
2023-04-11
Other registries' IDs
eudract:2018-004827-36

Source ClinicalTrials.gov

Registered outcomes15

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimarySequential organ failure assessment (SOFA) scoreday 5Change of total SOFA score from baseline to day 5 (in the subgroup defined by patients with elevated sTREM-1 baseline levels and in the overall population)
SecondaryAll-cause mortalityday 5 and day 28all-cause mortality on D5 and D28
SecondaryDuration of ICU stayday 28hospitalization
SecondaryOrgane support free survivalday 28time to organe support free
SecondarySepsis support index (SSI)day 28Sepsis support index
SecondaryDaily change of total Sequential organ failure assessment (SOFA) score and individual subscoresday 1, day 2, day 3, day 4, day 5, day 6 and day 7Daily change of total SOFA score and individual subscores
SecondaryDuration of Vasopressor useday 28Change in the Duration of Vasopressor use
SecondaryDuration of Invasive mechanical ventilation (IMV)day 28Change in the Duration of Invasive mechanical ventilation (IMV)
SecondaryDuration of Renal supportday 28Change in the Duration of renal replacement therapy, RRT
SecondaryAll-cause mortality12 monthsall-cause mortality up to 12 months

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers2

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
34233965DERIVEDPubMed
37269870DERIVEDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT04055909

GET https://conductscience.org/api/trials/v1/NCT04055909/registered